LifeVantage Corporation (NASDAQ:LFVN) Q1 2020 Results Earnings Conference Call October 30, 2019 4:30 PM ET
Scott Van Winkle - ICR
Darren Jensen - President, CEO
Steven Fife - CFO
Conference Call Participants
Doug Lane - Lane Research
Good day, ladies and gentlemen. Thank you for standing by. Welcome to today's Conference Call to discuss LifeVantage's First Fiscal Quarter of 2020 Financial Results. At this time, all participants are in a listen-only mode. Following the formal remarks, we will conduct a question-and-answer session. Instructions will be provided at that time for you to queue up. Hosting today's conference will be Scott Van Winkle with ICR.
As a reminder, today's conference is being recorded. And I would now like to turn the conference over to Mr. Van Winkle. Please go ahead, sir.
Scott Van Winkle
Thank you. Good afternoon, and welcome to LifeVantage Corporation's conference call to discuss results for the first fiscal quarter of 2020. On the call from LifeVantage with prepared remarks are Darren Jensen, CEO; and Steve Fife, Chief Financial Officer.
By now, everyone should have access to the earnings release, which we announced this afternoon at approximately 4:05 p.m. Eastern Time. If you have not received the release, it is available on the Investor Relations portion of LifeVantage's website at www.lifevantage.com. This call is being webcast, and a replay will be available on the company's website as well.
Before we begin, we would like to remind everyone that our prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. These statements do not guarantee future performance, and therefore, undue reliance should not be placed upon them. These statements are based on current expectations of the company's management and involve inherent risks and uncertainties, including those identified in the Risk Factors section of LifeVantage's most recently filed Forms 10-Q and 10-K.
Please note that during today's call, we will discuss non-GAAP financial measures, including results on an adjusted basis. Management believes these financial measures can facilitate a more complete analysis and greater transparency into LifeVantage's ongoing results of operations, particularly when comparing underlying operating results from period to period. We've included a reconciliation of these non-GAAP measures with today's release.
This call also contains time-sensitive information that is accurate only as of the date of this live broadcast, October 30, 2019. LifeVantage assumes no obligation to update any forward-looking projection that may be made in today's release or call.
Now I will turn the call over to the company's CEO, Darren Jensen.
Thank you, Scott, and good afternoon, everyone. It's a pleasure to be with you again today to discuss our first quarter fiscal 2020 results. During the quarter we are intensely focused on preparing to the launch of our most significant new product in recent years; Protandim and NAD Synergizer.
This revolutionary product is the first addition to our flagship Protandim line since 2016 and we're very pleased with the initial sales that consumer response, which is meeting our robust expectations and to date is shaping up as one of the strongest product launches.
We're the early days of the launch, but anticipate that October could be among the best sales month in our history. And we will continue to focus on building this product across our global footprint.
Before I discuss our progress with Protandim NAD Synergizer, let me recap the first quarter activity, which again were largely focused on preparation for this important launch.
Our year-over-year revenue growth continued during the quarter as we generated 1% increase, which significant mark the improvement in margins, adjusted EBITDA and net income. The revenue growth reflected strong year-over-year gains in Asia-Pacific and Europe which increased 10.4% including 10% growth in Japan.